Zheng Falei2017-09-15 09:28
Zheng Falei ,born in January 1947.He took part in Jiusan Society in 1984 and he had ever served as director of the Urology department ,Peking Union College Hospital .Now he is the committee member of the Jiusan society the eleventh central committee、director of the central medicine and health committee 、the tenth standing committee of the Beijing municipal committee 、the professor and Doctoral tutor of the Chinese Academy of Medical Sciences(CAMS) and Peking Union College Hospital.
Chronic kidney disease and end-stage kidney disease
Serve as a doctor for 40 years ,after 1979 he mainly worked on the clinic、research and teaching work of the kidney disease ,the research focus on chronic kidney metabolic disorders and nutritional therapy 、the mechanism and intervention of the renal interstitial 、renal tubular lesions and drug toxicity .In 1980s and 1990s ,he first reported the the protein and amino acid metabolism disorder of patients with chronic renal failure ,first applied essential amino acid and ketonic acid treat chronic renal failure and reported this treatment had effect on improve the protein 、acid metabolism disorder and delay the development of renal failure ,this research had ever won the second prize of Chinese academy of medical sciences in 1985.Later he reported the relationship between the changes of the uremic patient’s orexins 、leptin and metabolic acidosis .
He first reported the clinical and biochemical characteristics of type Ⅳ renal tubular acidosis in 1988.
In 1991 , he cooperated with his peers carried out the basis of the erythrogenin and the clinical research ,this research won the second prize of the national scientific and technological progress .
In the research of the renal toxicity mechanism found that the drugs would cause apoptosis of which related to the intracellular calcium ion concentration change .He and his partners won the second prize of the Chinese medicine in 2008.
In 1997,he studied the mechanism of aristolochic acid ,first made the animal models of chronic aristolochic acid nephropathy rats successfully in international and first reported renal tubular epithelial transdifferentiation is one of the pathogenesis of aristolochic acid nephropathy .
In 2007,he won the excellent paper award of the 90th anniversary of the Chinese medicine colleges in 2007.He had ever overtook and put across the National Natural Science Foundation of China(NSFC)、Beijing natural science fund project 、ministry of science and technology “five-year”、“the ninth five-year plan”、“fifteen”research project,as well as the ministry of health 、Chinese medicine college and other scientific fund programs .
After 1980 ,he had already published more than 260 medical papers ,including 3 parts of the editor in chief medical book ,1 part of the main translation ,and took part in 28 monographs and participate in the writing.In 1985 ,he won the second prize of the Chinese Academy of Medicine Science (CAMS) .
If you have other kidney problems that can be viewed on other web pages, you can also consult online, or in your email, email@example.com, we'll get back to you as soon as possible.